• FirefoxInstall the new Firefox »
  •  Dow Down 0.47% Nasdaq Down 0.56%

    Ironwood Pharmaceuticals, Inc. (IRWD)

    -NasdaqGS
    15.58 Down 0.29(1.83%) Mar 3, 4:00PM EST
    Add to Portfolio
    Prev Close:15.87
    Open:15.82
    Bid:N/A
    Ask:29.99 x 100
    1y Target Est:15.71
    Beta:1.2
    Earnings Date:Apr 27 - May 1 (Est.)
    Day's Range:15.40 - 15.88
    52wk Range:9.01 - 17.11
    Volume:453,864
    Avg Vol (3m):884,183
    Market Cap:2.20B
    P/E (ttm):N/A
    EPS (ttm):-1.39
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for IRWD

    Comparison

    Symbol% ChgMkt Cap
    IRWDDown 1.83%2.20B
    SHPGUp 1.05%46.74B
    SCMPUp 10.07%655.76M

    Key Statistics

    Forward P/E (1 yr):97.38
    P/S (ttm):29.31
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.59
    Quarterly EPS Est (Mar-15) :-0.23
    Mean Recommendation*:2.8
    PEG Ratio (5 yr expected):-1.39

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Ironwood Pharmaceuticals, Inc., an entrepreneurial pharmaceutical company, discovers, develops, and commercializes human therapeutic products. The company’s lead product candidate, linaclotide, a guanylate cyclase type-C agonist for irritable... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback